Latest News

World's largest study reveals risks

Read more

Prof. Dr. Dagmar Krefting is the new director of the Institute of Medical Informatics at the University Medical Center Göttingen. In September 2019, she had already taken over as acting director of the institute. Since 1 September 2021, the DZHK scientist has held the university...

Read more

The newly developed risk score predicts the 1-year risk of severe bleeding for patients after inpatient treatment for the symptomatic peripheral arterial disease (PAVK). Scientists from the University Medical Center Hamburg-Eppendorf (UKE) were involved in developing the score.

Read more

The current standard diagnostic test for intermediate-risk patients is is a minimally invasive catheter examination.Under the leadership of Charité – Universitätsmedizin Berlin, researchers from 31 European clinical institutions worked together to test cardiac CT as a...

Read more

On February 15, 2022, the Clinic for Rhythmology was founded at the Lübeck Campus of the University Hospital Schleswig-Holstein (UKSH). In this course, the Department of Electrophysiology of the Medical Clinic II was dissolved. Given the increasing specialization within...

Read more

Changes in the gut microbiome can ultimately lead to cardiovascular disease. Yet some of the alterations appear to normalize in chronic conditions, a team led by ECRC researcher Sofia Forslund reports in Nature Medicine. This finding may have clinical implications.

Read more

Cardiovascular diseases can be treated better today than ever before. At the same time, they remain among the leading causes of death. Understanding cardiovascular disease in detail is essential for further progress. Researchers from Hamburg, Lübeck and Munich have used a...

Read more

The interplay of genetics and epigenetics is a long-sought riddle in the development of diseases. Researchers from Helmholtz Munich and the Imperial College London discovered novel interactions. Their findings improve our knowledge about environmentally triggered diseases and may...

Read more

A research team led by Stefan Engelhardt, Professor of Pharmacology and Toxicology at the Technical University of Munich (TUM) and Principal Investigator at the DZHK, has developed a new RNA drug that can prevent inflammatory lung damage. The German Federal Ministry of Education...

Read more

Musclin, a hormone-like messenger substance of the skeletal muscle, protects against the pathological overload of the heart. For patients with chronic heart failure, the discovery could open up advances in therapy.

Read more